PIN50 A Cost-Effectiveness Analysis of Telaprevir Versus Boceprevir in the Treatment of Hepatitis C- A Greek National Health System Perspective
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1117
https://www.valueinhealthjournal.com/article/S1098-3015(12)02830-6/fulltext
Title :
PIN50 A Cost-Effectiveness Analysis of Telaprevir Versus Boceprevir in the Treatment of Hepatitis C- A Greek National Health System Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02830-6&doi=10.1016/j.jval.2012.08.1117
First page :
A394
Section Title :
Infection
Open access? :
No
Section Order :
620